China

Details

  • Service: Tax, Global Transfer Pricing Services (GTPS)
  • Industry: Infrastructure, Government and Healthcare, Healthcare
  • Type: Publication series, Regulatory update
  • Date: 3/31/2014

Transfer pricing focus for value chain management in pharmaceutical and medical device companies 

China Tax for Healthcare & Life Sciences Industry - Issue 2, March 2014

 

Transfer pricing is in the spotlight for our second issue of the China Tax for the Healthcare and Life Sciences Industry series.   We have outlined the specific concerns of pharmaceutical and medical device companies operating in China regarding their transfer pricing arrangements, as well as our key recommendations for:

  

  • Effectively managing the transfer pricing value chain in China;
  • Striking a sensible balance amongst the various regulatory authorities governing China’s healthcare companies regarding intercompany arrangements; and
  • Developing a feasible approach to mitigate detection and technical risk
 

Get in touch with KPMG China

 


 

Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.

 

 

China in focus

Newsletters - Our weekly and monthly newsletters summarise industry news, market trends and updates in regulations for the China and Asia Pacific regions.